EICOSANOIDS IN FOCAL SEGMENTAL GLOMERULOSCLEROSIS
类花生酸在局灶性节段性肾小球硬化中的作用
基本信息
- 批准号:6176746
- 负责人:
- 金额:$ 12.12万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1998
- 资助国家:美国
- 起止时间:1998-08-25 至 2003-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (adapted from the application)
Focal segmental glomerulosclerosis (FSGS) is a renal disease of unknown
etiology characterized by heavy proteinuria, hypertension, and progression
to renal failure. The incidence of FSGS has increased by up to 8-fold in
the past 20 years. It is the now the most common progressive glomerular
disease in children and account for 20_25% of nephrotic syndrome in
adults. Cyclooxygenase (COX) inhibitors decrease proteinuria in many
proteinuric glomerular disease, including FSGS. The applicant has
participated in studies that document the presence of a plasma factor in
patients with FSGS which causes an increase in glomerular albumin
permeability. In preliminary studies, she has shown that the COX inhibitor
indomethacin prevented the increased in albumin permeability caused by the
FSGS factor, thus implicating eicosanoids of the COX pathways of
arachidonic acid metabolism as mediators of this effect. In the proposed
studies, she will determine the role of these eicosanoids in mediating the
increased glomerular protein permeability caused by the FSGS factor, and
explore mechanisms by which this factor regulated synthesis of COX-derived
eicosanoids. Hypothesis to be tested are: (1) the FSGS factor increased
synthesis of specific eicosanoids of the COX pathway, and these
eicosanoids increase glomerular albumin permeability; (2) the FSGS factor
increases synthesis of COX-derived eicosanoids via an effect on activity
and/or expression of phospholipase A2 (PLA2), constitutive COX or
inducible COX. She will measure eicosanoid production by isolated
glomeruli or cultured glomerular cells after incubation with the FSGS
factor and will then determine the effect of eicosanoids identified in
these studies, on glomerular albumin permeability. Finally, she will
investigate the mechanism by which the FSGS factor enhance eicosanoid
synthesis by measuring activity and expression (mRNA and protein) of PLA,
and of constitutive and inducible COX in glomeruli and in cultured
glomerular cells. The proposed project is expected to provide the
applicant with valuable opportunities to expand hew knowledge and
expertise in experimental design, investigative techniques, and data
analysis. Results of these studies will provide insight into the
pathophysiology of FSGS. Additionally, they may lead to a better
understanding of the general mechanism by which proteinuria develops and
thus point to interventions that may alleviate or prevent proteinuria in
FSGS and in other glomerular diseases.
描述(改编自应用程序)
局灶节段性肾小球硬化症(FSGS)是一种未知的肾脏疾病,
病因学特征为大量蛋白尿、高血压和进展
到肾衰竭FSGS的发病率在2008年增加了8倍。
过去20年它是目前最常见的进行性肾小球疾病
占肾病综合征的20%~ 25
成年人了环氧合酶(考克斯)抑制剂可减少许多患者的蛋白尿
蛋白尿性肾小球疾病,包括FSGS。申请人已经
参与了一些研究,这些研究记录了
导致肾小球白蛋白升高的FSGS患者
磁导率在初步的研究中,她已经表明,考克斯抑制剂
吲哚美辛阻止了由白蛋白通透性增加引起的白蛋白通透性增加,
FSGS因子,从而暗示类花生酸的考克斯途径,
花生四烯酸代谢作为这种作用的介质。拟议
研究中,她将确定这些类二十烷酸在介导
由FSGS因子引起的肾小球蛋白渗透性增加,和
探索该因子调节COX衍生的合成的机制
类花生酸待检验的假设为:(1)FSGS因子增加
合成考克斯途径的特异性类花生酸,这些
类花生酸增加肾小球白蛋白通透性;(2)FSGS因子
通过对活性的影响增加COX衍生类二十烷酸的合成
和/或磷脂酶A2(PLA 2)、组成型考克斯或
诱导型考克斯。她将测量类花生酸的产生,
与FSGS孵育后的肾小球或培养的肾小球细胞
因素,然后确定中确定的类二十烷酸的影响
这些关于肾小球白蛋白渗透性的研究。最后,她会
研究FSGS因子增强类花生酸的机制
通过测量PLA的活性和表达(mRNA和蛋白质)合成,
以及肾小球和培养的肾小球中组成型和诱导型考克斯的表达。
肾小球细胞预计拟议项目将提供
申请人有宝贵的机会,以扩大新的知识和
实验设计、调查技术和数据方面的专业知识
分析.这些研究的结果将提供深入了解
FSGS的病理生理学此外,它们可能会导致更好的
了解蛋白尿发生的一般机制,
因此指出,干预措施,可以减轻或预防蛋白尿,
FSGS和其他肾小球疾病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ELLEN T MCCARTHY其他文献
ELLEN T MCCARTHY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ELLEN T MCCARTHY', 18)}}的其他基金
CYTOCHROME P-450 AND GLOMERULAR PROTEIN PERMEABILITY
细胞色素 P-450 和肾小球蛋白通透性
- 批准号:
7989312 - 财政年份:2009
- 资助金额:
$ 12.12万 - 项目类别:
CYTOCHROME P-450 AND GLOMERULAR PROTEIN PERMEABILITY
细胞色素 P-450 和肾小球蛋白通透性
- 批准号:
6870441 - 财政年份:2005
- 资助金额:
$ 12.12万 - 项目类别:
CYTOCHROME P-450 AND GLOMERULAR PROTEIN PERMEABILITY
细胞色素 P-450 和肾小球蛋白通透性
- 批准号:
7194298 - 财政年份:2005
- 资助金额:
$ 12.12万 - 项目类别:
CYTOCHROME P-450 AND GLOMERULAR PROTEIN PERMEABILITY
细胞色素 P-450 和肾小球蛋白通透性
- 批准号:
7368066 - 财政年份:2005
- 资助金额:
$ 12.12万 - 项目类别:
CYTOCHROME P-450 AND GLOMERULAR PROTEIN PERMEABILITY
细胞色素 P-450 和肾小球蛋白通透性
- 批准号:
7020694 - 财政年份:2005
- 资助金额:
$ 12.12万 - 项目类别:
CYTOCHROME P-450 AND GLOMERULAR PROTEIN PERMEABILITY
细胞色素 P-450 和肾小球蛋白通透性
- 批准号:
7567555 - 财政年份:2005
- 资助金额:
$ 12.12万 - 项目类别:
CYTOCHROME P-450 AND GLOMERULAR PROTEIN PERMEABILITY
细胞色素 P-450 和肾小球蛋白通透性
- 批准号:
7260132 - 财政年份:2005
- 资助金额:
$ 12.12万 - 项目类别:
Effects of FSGS factor on arachidonic acid metabolism
FSGS因子对花生四烯酸代谢的影响
- 批准号:
6464306 - 财政年份:2002
- 资助金额:
$ 12.12万 - 项目类别:
Effects of FSGS factor on arachidonic acid metabolism
FSGS因子对花生四烯酸代谢的影响
- 批准号:
6623268 - 财政年份:2002
- 资助金额:
$ 12.12万 - 项目类别:
EICOSANOIDS IN FOCAL SEGMENTAL GLOMERULOSCLEROSIS
类花生酸在局灶性节段性肾小球硬化中的作用
- 批准号:
2677006 - 财政年份:1998
- 资助金额:
$ 12.12万 - 项目类别:
相似海外基金
Post-translational modifications control JARID enzyme activity during DNA damage
翻译后修饰控制 DNA 损伤期间 JARID 酶的活性
- 批准号:
10817495 - 财政年份:2023
- 资助金额:
$ 12.12万 - 项目类别:
Modulating Fibrinolysis Dynamics by Leveraging Multivalent Avidity to Control Enzyme Activity
通过利用多价亲和力控制酶活性来调节纤维蛋白溶解动力学
- 批准号:
10635496 - 财政年份:2023
- 资助金额:
$ 12.12万 - 项目类别:
Epigenetic mechanism of adipocyte differentiation through the regulation of enzyme activity
通过酶活性调节脂肪细胞分化的表观遗传机制
- 批准号:
23H02956 - 财政年份:2023
- 资助金额:
$ 12.12万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Functional Ocular Chemoproteomics for Retinal Biology Insight and in vivo Enzyme Activity
用于视网膜生物学洞察和体内酶活性的功能性眼部化学蛋白质组学
- 批准号:
10667228 - 财政年份:2023
- 资助金额:
$ 12.12万 - 项目类别:
Post-translational modifications control JARID enzyme activity during DNA damage
翻译后修饰控制 DNA 损伤期间 JARID 酶的活性
- 批准号:
10651974 - 财政年份:2023
- 资助金额:
$ 12.12万 - 项目类别:
In Vivo Mapping of Enzyme Activity using SWIR-emitting, Self-illuminating Quantum Dot Sensors
使用短波红外发射、自发光量子点传感器绘制酶活性体内图谱
- 批准号:
10762565 - 财政年份:2022
- 资助金额:
$ 12.12万 - 项目类别:
Enzyme activity levels in sprouted wheat
发芽小麦的酶活性水平
- 批准号:
571836-2022 - 财政年份:2022
- 资助金额:
$ 12.12万 - 项目类别:
University Undergraduate Student Research Awards
Establishment and operation of a method for evaluating enzyme activity in VLCAD and MCAD
VLCAD和MCAD酶活性评价方法的建立和运行
- 批准号:
21K07753 - 财政年份:2021
- 资助金额:
$ 12.12万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The development of methods to control enzyme activity using protein-protein splicing and virus-like particles
开发利用蛋白质-蛋白质剪接和病毒样颗粒控制酶活性的方法
- 批准号:
21K19397 - 财政年份:2021
- 资助金额:
$ 12.12万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
The effect of TBI induced calcium influx on mitochondrial enzyme activity
TBI诱导的钙内流对线粒体酶活性的影响
- 批准号:
564646-2021 - 财政年份:2021
- 资助金额:
$ 12.12万 - 项目类别:
University Undergraduate Student Research Awards